Publicaciones (35) Publicaciones de CAROLINA TORRES PERALES

2022

  1. Perioperative Broad-spectrum Antibiotics are Associated with Decreased Surgical Site Infections Compared to 1st-3rd Generation Cephalosporins after Open Pancreaticoduodenectomy in Patients with Jaundice or a Biliary Stent

    Annals of Surgery, Vol. 275, Núm. 6, pp. 1175-1183

2021

  1. Liquid biopsy approach to pancreatic cancer

    World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287

  2. Role of stromal activin A in human pancreatic cancer and metastasis in mice

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer

    Asian Journal of Pharmaceutical Sciences, Vol. 15, Núm. 2, pp. 237-251

  2. Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12

2019

  1. Knockout of Acinar Enriched microRNAs in Mice Promote Duct Formation But Not Pancreatic Cancer

    Scientific reports, Vol. 9, Núm. 1, pp. 11147

  2. P110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 29, pp. 14724-14733

  3. TGFb blockade augments PD-1 inhibition to promote T-cell–mediated regression of pancreatic cancer

    Molecular Cancer Therapeutics, Vol. 18, Núm. 3, pp. 613-620

2018

  1. Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers

    PLoS ONE, Vol. 13, Núm. 4

  2. KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs

    Scientific Reports, Vol. 8, Núm. 1

  3. Omega-3 fatty acids prevent early pancreatic carcinogenesis via repression of the AKT pathway

    Nutrients, Vol. 10, Núm. 9

  4. Pancreatic cancer subtypes: a roadmap for precision medicine

    Annals of Medicine, Vol. 50, Núm. 4, pp. 277-287

  5. Proteomic biomarkers in body fluids associated with pancreatic cancer

    Oncotarget, Vol. 9, Núm. 23, pp. 16573-16587

  6. The complexity of omega-3 fatty acid modulation of signaling pathways related to pancreatic cancer

    Current Medicinal Chemistry, Vol. 25, Núm. 22, pp. 2608-2623

2017

  1. TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function

    Oncogene, Vol. 36, Núm. 30, pp. 4336-4348

2016

  1. Cholesterol loading in vivo and in vitro alters extracellular matrix proteins production in smooth muscle cells

    European Journal of Lipid Science and Technology, Vol. 118, Núm. 9, pp. 1317-1325

  2. Current status of immunotherapy treatments for pancreatic cancer

    Journal of Clinical Gastroenterology, Vol. 50, Núm. 10, pp. 836-848

  3. Effect of HMG-CoA reductase inhibition on vascular smooth muscle cells extracellular matrix production: Role of RhoA

    Current Vascular Pharmacology, Vol. 14, Núm. 4, pp. 345-352

  4. Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients

    Toxicology and Applied Pharmacology, Vol. 311, pp. 113-116

  5. Inhibition of extracellular matrix production and remodeling by doxycycline in smooth muscle cells

    Journal of Pharmacological Sciences, Vol. 132, Núm. 4, pp. 218-223